PR Newswire Transaction to extend Labcorp’s leadership in oncology and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 11, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference […]
Search Results for: test services
Press Release
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
26
Aug
Aug
New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]
Press Release
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
19
Dec
Dec
ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]
MIAMI–(BUSINESS WIRE)– OPKO Health, Inc. (NYSE:OPK) today announced that it has entered into agreements with Stratose, Three Rivers Provider Network and Fortified Provider Network for testing services from OPKO Lab, including the 4Kscore®Test, the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive cancer. The cumulative contracts, with some of the largest healthcare PPO network […]
21
Feb
Feb
Clinical testing and genomic insights have revolutionized the way disease is understood, which has enabled personalized treatment approaches that can be tailored to an individual’s unique genetic makeup. Harnessing the potential of genomic testing and its cutting-edge technology can significantly benefit patient outcomes. Read on to learn how BioReference® is supporting genomic testing and clinical […]
09
May
May
National Women’s Health Week is an annual initiative driven by the U.S. Department of Health and Human Services that aims to raise awareness and encourage women to make their health a priority. While finding the time and resources to properly manage one’s health may feel overwhelming, there are many actionable ways women can take to […]
23
Aug
Aug
If you’re packing up to head back to campus or are sending off a scholar – the start of a new semester is the perfect time to encourage sexual health education. Staying informed about the heightened risk for sexually transmitted infections that college students may face is an important factor in supporting sexual and overall […]
20
Sep
Sep
As data from public health entities continues to emerge about COVID-19 and the Delta variant, we have learned it is more infectious and leading to increased transmissibility when compared with other variants. With the Delta variant accounting for more than 93% of new COVID-19 cases and being more than 2x as contagious as previous variants, according […]
BioReference is currently testing students and staff from two of the five largest school districts in the nation and is prepared to rapidly expand COVID-19 school testing to other school districts across the country ELMWOOD PARK, N.J., March 26, 2021 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the expansion of its COVID-19 school […]
360Dx NEW YORK – On Opko’s conference call to discuss its fourth quarter earnings results, subsidiary BioReference Laboratories emphasized the demand it has seen for rapid point-of-care tests for SARS-CoV-2 as the pandemic rages on. BioReference Executive Chairman Jon Cohen said on the call that the laboratory has performed 100,000 rapid SARS-CoV-2 tests to date, adding that […]
